TITLE

Anti-VEGF more effective than photocoagulation, combination therapy in treating DME

AUTHOR(S)
Bird, Alan C.
PUB. DATE
December 2008
SOURCE
Ocular Surgery News Europe/Asia-Pacific Edition;Dec2008, Vol. 19 Issue 12, p14
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
The article reports on results of the Ranibizumab for Edema of the Macula in Diabetes Phase 2 (READ 2) Study, presented by Peter A Campochiaro at the 2008 American Academy of Ophthalmology meeting. The findings showed a mean improvement in visual acuity over time in ranibizumab-alone group. In this group, patients received monthly injections, then every other month to match up with the combination group that had an injection, then one month later had laser.
ACCESSION #
35376211

 

Related Articles

  • Anti-VEGF shows good results in treating DME at 12 months. Campochiaro, Peter A. // Ocular Surgery News Europe/Asia-Pacific Edition;Dec2008, Vol. 19 Issue 12, p12 

    The article reports on the effectiveness of ranibizumab for the treatment of diabetic macular edema, according to a presentation by Pascale G. Massin at the 2008 American Academy of Ophthalmology meeting. Efficacy in ranibizumab-treated patients during the phase 2 RESOLVE study showed clinical...

  • VA increases or remains stable after ranibizumab treatment for nonischemic retinal vein occlusion. Groves, Nancy; Pece, Alfredo // Ophthalmology Times;2/1/2009, Vol. 34 Issue 3, p25 

    The article examines the potential effectiveness of ranibizumab or the Lucentis drug introduced by Genentech Inc. in treating retinal vein occlusion. During the annual meeting of the American Academy of Ophthalmology, Alfredo Pece shares that a study with patients suffering from nonischemic...

  • Antioxidant drop could he advance against dry AMD. Charters, Lynda; Sternberg Jr., Paul // Ophthalmology Times;2/1/2009, Vol. 34 Issue 3, p28 

    The article examines the report by Paul Sternberg Jr. delivered during the annual meeting of the American Academy of Ophthalmology in the U.S. An affiliate of the Vanderbilt Eye Institute, Vanderbilt, University of Medicine, Nashville, Tennessee, Sternberg announces that the drug might be found...

  • Data show FAc improves CVA in patients with DME.  // Optometry Times;Jun2011, Vol. 3 Issue 6, p6 

    The article discusses findings from a Fluocinolone Acetonide in Diabetic Macular Edema (FAME) study of a fluocinolone acetonide (FAc) intravitreal insert presented at the Association for Research in Vision and Ophthalmology (ARVO) annual meeting which showed improvement in corrected visual...

  • Anti-VEGF more effective than photocoagulation, combination therapy in treating DME.  // Ocular Surgery News;12/10/2008, Vol. 26 Issue 23, p15 

    The article discusses the highlights of the American Academy of Ophthalmology meeting that was held in Atlanta, Georgia from November 8 to 11, 2008. Ophthalmologist Peter A. Campochiaro reported that diabetic macular edema regresses more after treatment with ranibizumab rather than laser...

  • Pegaptanib sodium effective, safe for DME. Sultan, Maria // Ophthalmology Times;11/1/2010, Vol. 35 Issue 21, p24 

    The article reports on the phase III study on visual acuity measurement which reveals that pegaptanib sodium injection is an effective and safe treatment for diabetic macular edema (DME). According to doctor Marla Sultan during the annual meeting of the American Academy of Ophthalmology, the...

  • Glaucoma, non-glaucoma patients who underwent DSEK had similar high IOP, visual outcomes. Sarkisian Jr., Steven R. // Ocular Surgery News Europe/Asia-Pacific Edition;Dec2008, Vol. 19 Issue 12, p12 

    The article discusses results of a study on visual acuity for glaucoma and non-glaucoma patients after Descemet's stripping endothelial keratoplasty (DSEK), as presented by Thasarat S. Vajaranant at the 2008 American Academy of Ophthalmology meeting. Vajaranant and colleagues found that the...

  • Ocriplasmin aids hole closure. Charters, Lynda // Ophthalmology Times;3/1/2012, Vol. 37 Issue 5, p30 

    The article focuses on the data from the Microplasmin for Vitreous Injection (MIVI) Traction Release without Surgical Treatment (TRUST) phase III program, presented by doctor Peter K. Kaiser at the American Academy of Ophthalmology's annual meeting. The program included patients who had...

  • Association between external limiting membrane status and visual acuity in diabetic macular oedema. Kashani, Shahram // Current Medical Literature: Ophthalmology;2013, Vol. 23 Issue 2, p75 

    The article discusses research that examined the association between external limiting membrane (ELM) status and visual acuity in diabetic macular edema (DME). It reference a study by S. Ito and colleagues, published in the 2013 issue of the "British Journal of Ophthalmology." Findings show that...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics